4-15968315-T-C

Variant names:

• chr4-15968315-T-C
• rs3130
• NM_006017.3:c.*1078A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_006017.3(PROM1):​c.*1078A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.541 in 152,064 control chromosomes in the GnomAD database, including 22,803 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.54 (22803 hom., cov: 32)
  • Failed GnomAD Quality Control
• Consequence: PROM1 NM_006017.3 3_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:5
• Conservation: PhyloP100: 0.199
• Publications: 28 publications found

Genes affected

PROM1 (HGNC:9454): (prominin 1) This gene encodes a pentaspan transmembrane glycoprotein. The protein localizes to membrane protrusions and is often expressed on adult stem cells, where it is thought to function in maintaining stem cell properties by suppressing differentiation. Mutations in this gene have been shown to result in retinitis pigmentosa and Stargardt disease. Expression of this gene is also associated with several types of cancer. This gene is expressed from at least five alternative promoters that are expressed in a tissue-dependent manner. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

FGFBP2 (HGNC:29451): (fibroblast growth factor binding protein 2) This gene encodes a member of the fibroblast growth factor binding protein family. The encoded protein is a serum protein that is selectively secreted by cytotoxic lymphocytes and may be involved in cytotoxic lymphocyte-mediated immunity. An increase in the amount of gene product may be associated with atopic asthma and mild extrinsic asthma.[provided by RefSeq Staff, Oct 2008]

ACMG classification

Our verdict: Benign. The variant received -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.88).
• BP6: Variant 4-15968315-T-C is Benign according to our data. Variant chr4-15968315-T-C is described in ClinVar as Benign. ClinVar VariationId is 347963.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.698 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006017.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	PROM1	NM_006017.3	MANE Select	c.*1078A>G		3_prime_UTR	Exon 28 of 28	NP_006008.1	O43490-1
	PROM1	NM_001145847.2		c.*1078A>G		3_prime_UTR	Exon 27 of 27	NP_001139319.1	O43490-2
	PROM1	NM_001145848.2		c.*1078A>G		3_prime_UTR	Exon 27 of 27	NP_001139320.1	O43490-2

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	PROM1	ENST00000447510.7	TSL:1 MANE Select	c.*1078A>G		3_prime_UTR	Exon 28 of 28	ENSP00000415481.2	O43490-1
	PROM1	ENST00000505450.5	TSL:1	c.*1078A>G		3_prime_UTR	Exon 27 of 27	ENSP00000426090.1	O43490-2
	PROM1	ENST00000508167.5	TSL:1	c.*1078A>G		3_prime_UTR	Exon 27 of 27	ENSP00000427346.1	O43490-2

Frequencies

GnomAD3 genomes AF: 0.541 AC: 82215 AN: 151946 Hom.: 22785 Cov.: 32

Gnomad AFR AF: 0.432

Gnomad AMI AF: 0.816

Gnomad AMR AF: 0.625

Gnomad ASJ AF: 0.588

Gnomad EAS AF: 0.657

Gnomad SAS AF: 0.718

Gnomad FIN AF: 0.635

Gnomad MID AF: 0.551

Gnomad NFE AF: 0.547

Gnomad OTH AF: 0.543

GnomAD4 exome Data not reliable, filtered out with message: AC0 AC: 0 AN: 0 Hom.: 0 Cov.: 0 AC XY: 0 AN XY: 0

African (AFR) AC: 0 AN: 0

American (AMR) AC: 0 AN: 0

Ashkenazi Jewish (ASJ) AC: 0 AN: 0

East Asian (EAS) AC: 0 AN: 0

South Asian (SAS) AC: 0 AN: 0

European-Finnish (FIN) AC: 0 AN: 0

Middle Eastern (MID) AC: 0 AN: 0

European-Non Finnish (NFE) AC: 0 AN: 0

Other (OTH) AC: 0 AN: 0

GnomAD4 genome AF: 0.541 AC: 82277 AN: 152064 Hom.: 22803 Cov.: 32 AF XY: 0.551 AC XY: 40992 AN XY: 74342

African (AFR) AF: 0.432 AC: 17910 AN: 41450

American (AMR) AF: 0.625 AC: 9554 AN: 15288

Ashkenazi Jewish (ASJ) AF: 0.588 AC: 2042 AN: 3470

East Asian (EAS) AF: 0.656 AC: 3397 AN: 5176

South Asian (SAS) AF: 0.718 AC: 3465 AN: 4826

European-Finnish (FIN) AF: 0.635 AC: 6707 AN: 10554

Middle Eastern (MID) AF: 0.538 AC: 157 AN: 292

European-Non Finnish (NFE) AF: 0.547 AC: 37163 AN: 67988

Other (OTH) AF: 0.540 AC: 1139 AN: 2110

Alfa AF: 0.538 Hom.: 34380

Bravo AF: 0.533

Asia WGS AF: 0.704 AC: 2448 AN: 3478

ClinVar

ClinVar submissions

Significance: Benign

Revision: criteria provided, multiple submitters, no conflicts

Pathogenic	VUS	Benign	Condition
-	-	1	Cone-rod dystrophy 12 (1)
-	-	1	not provided (1)
-	-	1	Retinal macular dystrophy type 2 (1)
-	-	1	Retinitis pigmentosa (1)
-	-	1	Stargardt disease 4 (1)

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.88
CADD	Benign	3.3
DANN	Benign	0.59
PhyloP100		0.20
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs3130; hg19: chr4-15969938;